Together, these data suggest that IL1β may be a key effector molecule executing the proinflammatory function of NEUs, MONs and MACs, and that IFNγ may play an upstream role in activating MACs during ACD pathogenesis. Here, IL1B is linked to granular corneal dystrophy type II.